Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||
---|---|---|---|---|---|---|
fig.6.g
Ding Y et al. (2017) |
Xla Wt + pkdcc.1
NF16 (morphology) |
|
||||
fig.1.e
Eroshkin FM et al. (2016) |
Xla Wt + nog
NF15 (in situ hybridization) |
|
||||
fig.S3.h
Eroshkin FM et al. (2016) |
Xla Wt + nog4
NF15 (in situ hybridization) |
|
||||
fig.S5.b
Eroshkin FM et al. (2016) |
Xla Wt + nog4
NF15 (in situ hybridization) |
|
||||
fig.1.f
Eroshkin FM et al. (2016) |
Xla Wt + nog4 MO
NF15 (in situ hybridization) |
|
||||
fig.S3.i
Eroshkin FM et al. (2016) |
Xla Wt + nog4 MO
NF15 (in situ hybridization) |
|
||||
fig.2.c
Miyagi A et al. (2015) |
Xla Wt + flop2 MO
NF17-18 (in situ hybridization) |
|
||||
fig.2.c
Miyagi A et al. (2015) |
Xla Wt + flop2 MO + mgc69520 MO
NF17-18 (in situ hybridization) |
|
||||
fig.2.c
Miyagi A et al. (2015) |
Xla Wt + mgc69520 MO
NF17-18 (in situ hybridization) |
|
||||
fig.S3.e
Zhang X et al. (2012) |
Xtr Wt + trabd2a MO
NF16 (in situ hybridization) |
|